Development of a dual-component infection-resistant arterial replacement for small-caliber reconstructions: A proof-of-concept study
Introduction: Synthetic vascular grafts perform poorly in small-caliber (<6mm) anastomoses, due to intimal hyperplasia and thrombosis, whereas homografts are associated with limited availability and immunogenicity, and bioprostheses are prone to aneurysmal degeneration and calcification. Infection is another important limitation with vascular grafting. This study developed a dual-component graft for small-caliber reconstructions, comprising a decellularized tibial artery scaffold and an antibiotic-releasing, electrospun polycaprolactone (PCL)/polyethylene glycol (PEG) blend sleeve.
Methods: The study investigated the effect of nucleases, as part of the decellularization technique, and two sterilization methods (peracetic acid and γ-irradiation), on the scaffold’s biological and biomechanical integrity. It also investigated the effect of different PCL/PEG ratios on the antimicrobial, biological and biomechanical properties of the sleeves. Tibial arteries were decellularized using Triton X-100 and sodium-dodecyl-sulfate.
Results: The scaffolds retained the general native histoarchitecture and biomechanics but were depleted of glycosaminoglycans. Sterilization with peracetic acid depleted collagen IV and produced ultrastructural changes in the collagen and elastic fibers. The two PCL/PEG ratios used (150:50 and 100:50) demonstrated differences in the structural, biomechanical and antimicrobial properties of the sleeves. Differences in the antimicrobial activity were also found between sleeves fabricated with antibiotics supplemented in the electrospinning solution, and sleeves soaked in antibiotics.
Discussion: The study demonstrated the feasibility of fabricating a dual-component small-caliber graft, comprising a scaffold with sufficient biological and biomechanical functionality, and an electrospun PCL/PEG sleeve with tailored biomechanics and antibiotic release.
Funding
People Programme (Marie Curie Actions) of the EU seventh Framework Programme FP7/2007–2013/ under the TECAS-ITN (317512)
German Research Foundation through the Cluster of Excellence REBIRTH (EXC 62)
Guided Functional Re-engineering of the Mitral Valve
Engineering and Physical Sciences Research Council
Find out more...German Academic Exchange Service (DAAD)
History
School
- Mechanical, Electrical and Manufacturing Engineering
Published in
Frontiers in Bioengineering and BiotechnologyVolume
11Publisher
Frontiers MediaVersion
- VoR (Version of Record)
Rights holder
© The AuthorsPublisher statement
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) https://creativecommons.org/licenses/by/4.0/. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.Acceptance date
2023-01-02Publication date
2023-01-18Copyright date
2023eISSN
2296-4185Publisher version
Language
- en